Intravenous Infusions is trading GHS 0.60 (+9.09%) after extending its recent rebound from GHS 0.40 on August 12, 2026.

  • No company-specific announcement dated August 21, 2026 was identified.
  • August 4 results reported a return to profitability, but they are not fresh enough to establish direct causation for today’s move.
  • Broader market sentiment is positive, though Ghana-specific confirmation is limited; recent gains suggest continued momentum and possible speculative buying.